Medications
New evidence for use of anti-inflammatory therapy for prevention of recurrent vascular events in stroke
In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organization Conference (ESOC 2024), anti-inflammatory treatment with long-term colchicine did not reduce rates of recurrent stroke ...
11 hours ago
0
0